FB102 is designed to block CD122 to selectively modulate IL-2 and IL-15 pathways that cause inflammation while preserving regulatory T-cell function and immune balance.

Overview Debates Related claims Topics Sources

Mice deficient in ENT1 exhibited reduced liver adenosine levels and protection against inflammation, fibrosis, and excessive liver fat accumulation.

Inflammatory bowel disease treatments rely on anti-inflammatory and immune-suppressing drugs, though many patients fail to respond to these medications.

When consumed through red meat, Neu5Gc accumulates in human tissues as a foreign xeno-autoantigen, triggering antibody responses and persistent inflammation known as xenosialitis.

Ulcerative colitis is a chronic inflammatory condition causing inflammation and ulcers in the digestive tract of affected patients

Satralizumab is a humanized monoclonal antibody designed to bind to soluble and membrane-bound interleukin-6 receptors, inhibiting interleukin-6-mediated inflammatory signaling

Clinical research shows semaglutide slows kidney disease progression through mechanisms including blood sugar, blood pressure, and inflammation improvements.

Semaglutide administration improved liver tissue findings, including reduced inflammation and liver scarring, among patients with metabolic dysfunction-associated steatohepatitis in a New England Journal of Medicine trial.

A National Jewish Health study in JCI Insight showed that a five-day e-cigarette vapor exposure caused lasting changes in Th1 immunity, weakening antiviral defenses and increasing susceptibility to respiratory infections.

In preclinical testing, the experimental compound GPPD simultaneously improved fat accumulation, inflammation, liver injury, and fibrosis while demonstrating an encouraging safety profile with no significant toxicity.

A preclinical study co-led by Cedars-Sinai Health Sciences University identified UBE2N as a potential therapeutic target; restoring its levels in laboratory mice reduced fat accumulation, inflammation, and scarring, suggesting its potential to prevent MASLD from advancing to MASH.

Daxdilimab targets and depletes plasmacytoid dendritic cells, whereas litifilimab targets BDCA2 receptors on plasmacytoid dendritic cells to downregulate them without causing depletion

Daxdilimab is an investigational human immunoglobulin G subclass 1 monoclonal antibody that binds to immunoglobulin-like transcript 7, resulting in a targeted depletion of plasmacytoid dendritic cells associated with inflammation and skin lesions in cutaneous lupus erythematosus

Across 24 safety-evaluable patients treated with Adicet Bio's prula-cel, there were no cases of cytokine release syndrome greater than Grade 2, no IEC-HS, no ICANS, and no graft-versus-host disease.

In the Phase 1 trial of Adicet Bio's prula-cel, Grade 1 or 2 cytokine release syndrome occurred in 25% of patients, while Grade 3 or higher infections occurred in 8.3% of patients.

Unlike personalized alpha-beta CAR-T therapies, Adicet Bio's prula-cel utilizes gamma-delta T cells, which are designed to secrete fewer inflammatory cytokines and reduce immune-related side effects.

The University of Rochester Medicine study showed that circadian interventions in mice after a stroke led to lower levels of inflammatory cytokines in the brain.

University of Rochester Medicine researchers suggest that stroke impairs glymphatic function, causing a failure in the clearance of inflammatory signaling molecules that leads to tissue damage.

Genicular artery embolization is a minimally invasive outpatient procedure that works by releasing tiny beads to reduce blood flow to targeted, abnormal blood vessels associated with painful, inflamed areas inside the knee joint.

The clinical theory behind genicular artery embolization is that reducing blood flow to inflamed areas calms inflammation, which in turn reduces swelling and pain inside the knee joint.

AstraZeneca's tozorakimab targets interleukin-33, a protein released by damaged cells that drives airway inflammation and mucus production in chronic obstructive pulmonary disease